The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

OrderlyMeds, a provider of compounded versions of GLP-1 weight loss drugs, including Eli Lilly’s (NYSE:LLY) tirzepatide, said on Friday that a cease-and-desist letter sent by the pharma giant would ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Weight loss platform Noom launched a full-page print ad in The Wall Street Journal this week, calling on policymakers to create new guidance around expensive drugs, as compounded GLP-1s are set to be ...

Meghan Trainor and husband Daryl Sabara opened up about their health journeys, which has included them both opting to take ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic ...

Harbor Diversified International All Cap Fund (Institutional Class) returned -7.58%, performing broadly in line with MSCI All ...

The Harbor International Fund returned -8.22%, slightly underperforming its benchmark, the MSCI EAFE (ND) Index, which returned -8.11%.

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high ...